CMAC installs supercomputer to drive AI for sustainable future medicines manufacturing research

Posted on 5 Jul 2023 by The Manufacturer
Murray Robertson (left), and Blair Johnston, respectively Research Fellow and Associate Director (academic) at CMAC, with the computer. Photo credit is CMAC
Murray Robertson (left), and Blair Johnston, respectively Research Fellow and Associate Director (academic) at CMAC, with the NVIDIA DGX H100 supercomputer. Photo credit: CMAC

The University of Strathclyde’s Continuous Manufacturing and Advanced Crystallisation (CMAC) medicines manufacturing research centre has installed a new NVIDIA DGX H100 supercomputer, becoming the first university centre in the United Kingdom to have this groundbreaking platform to enable the next wave of artificial intelligence (AI) research and development.

“This investment demonstrates our commitment to drive the digital transformation of CMC (Chemistry, Manufacturing and Control) processes for medicines development and manufacture. This groundbreaking infrastructure will allow us to work with our partners to develop novel AI solutions that will help us to produce new medicines more quickly, more affordably and with greater resilience of…

You've just hit your daily non-subscriber article limit. Subscribe now for FREE to read the full article.